Metastatic breast cancer is the most advanced type of breast cancer in which the tumour cells spread beyond the breast to other parts of the body, potentially affecting the bones, liver, lungs, or brain. While progress in patient care has been made in the past decade, there is still a need for improvements in care and support among patients living with the disease.
Pfizer is sponsoring the Advancing Care for Patients Living with mBC innovation challenge, in collaboration with Health 2.0, to encourage healthcare innovators to harness technology, develop cutting edge solutions and improve the lives of patients living with mBC!
The challenge encourages you to create meaningful solutions and improve mBC patients' overall quality of life. There are three phases to the challenge:
- Phase 1: calls for the development of creative concepts that address key patient needs - submissions are due 2nd December 2016.
- Phase 2: five semi-finalists will be selected to move on to this phase where mentorship will be provided by industry experts. A mid-challenge pitch during this phase will determine three finalists to advance to Phase 3.
- Phase 3: Finalists will demo their prototypes at a live pitch in May 2017, where a grand prize winner will be selected.
There is up to $250,000 in prize funding available.